162 related articles for article (PubMed ID: 16213718)
1. New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies.
Urbani P; Cavallo P; Cascio MG; Buonerba M; De Martino G; Di Marzo V; Saturnino C
Bioorg Med Chem Lett; 2006 Jan; 16(1):138-41. PubMed ID: 16213718
[TBL] [Abstract][Full Text] [Related]
2. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
3. First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligands.
Appendino G; Cascio MG; Bacchiega S; Moriello AS; Minassi A; Thomas A; Ross R; Pertwee R; De Petrocellis L; Di Marzo V
FEBS Lett; 2006 Jan; 580(2):568-74. PubMed ID: 16406364
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
Lambert DM; Fowler CJ
J Med Chem; 2005 Aug; 48(16):5059-87. PubMed ID: 16078824
[No Abstract] [Full Text] [Related]
5. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.
Brizzi A; Brizzi V; Cascio MG; Bisogno T; Sirianni R; Di Marzo V
J Med Chem; 2005 Nov; 48(23):7343-50. PubMed ID: 16279794
[TBL] [Abstract][Full Text] [Related]
7. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
Ortar G; Ligresti A; De Petrocellis L; Morera E; Di Marzo V
Biochem Pharmacol; 2003 May; 65(9):1473-81. PubMed ID: 12732359
[TBL] [Abstract][Full Text] [Related]
8. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
Reggio PH; Traore H
Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, binding studies and molecular modeling of novel cannabinoid receptor ligands.
Osman NA; Mahmoud AH; Allarà M; Niess R; Abouzid KA; Di Marzo V; Abadi AH
Bioorg Med Chem; 2010 Dec; 18(24):8463-77. PubMed ID: 21074998
[TBL] [Abstract][Full Text] [Related]
10. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
[TBL] [Abstract][Full Text] [Related]
11. Targeted stable-isotope dilution GC-MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma.
Zoerner AA; Gutzki FM; Suchy MT; Beckmann B; Engeli S; Jordan J; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2909-23. PubMed ID: 19414283
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors.
López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Fowler CJ; Tiger G; de Lago E; Fernández-Ruiz J; Ramos JA
Eur J Med Chem; 2003 Apr; 38(4):403-12. PubMed ID: 12750028
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A
Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252
[TBL] [Abstract][Full Text] [Related]
14. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.
López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Fowler CJ; Tiger G; de Lago E; Fernández-Ruiz J; Ramos JA
J Med Chem; 2003 Apr; 46(8):1512-22. PubMed ID: 12672252
[TBL] [Abstract][Full Text] [Related]
16. Novel natural and synthetic ligands of the endocannabinoid system.
Hanus LO; Mechoulam R
Curr Med Chem; 2010; 17(14):1341-59. PubMed ID: 20166928
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
Gertsch J
Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
[TBL] [Abstract][Full Text] [Related]
18. Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories.
Barnett-Norris J; Guarnieri F; Hurst DP; Reggio PH
J Med Chem; 1998 Nov; 41(24):4861-72. PubMed ID: 9822555
[TBL] [Abstract][Full Text] [Related]
19. From cannabis to cannabinergics: new therapeutic opportunities.
Goutopoulos A; Makriyannis A
Pharmacol Ther; 2002 Aug; 95(2):103-17. PubMed ID: 12182958
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, cannabinoid receptor activity, and enzymatic stability of reversed amide derivatives of arachidonoyl ethanolamide.
Parkkari T; Savinainen JR; Raitio KH; Saario SM; Matilainen L; Sirviö T; Laitinen JT; Nevalainen T; Niemi R; Järvinen T
Bioorg Med Chem; 2006 Aug; 14(15):5252-8. PubMed ID: 16644227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
